The product leverages the power of AI applications, expert services and an advanced AI platform to make it easy for you to discover, build, operate and share results. Wisecube can truly accelerate how your run your life sciences R&D projects.
- Novel Drug Design. Reducing the costs of bringing new drugs to market is becoming critical for pharmaceutical manufacturers. As regulations and development time get in the way, it becomes imperative to find any advantage. With Wisecube, you can effectively generate the right compounds used in developing your next test pipeline, using advanced AI techniques like deep neural networks and reduce the risk of failure.
- Compound Acquisition. Purchasing lists of small and large molecules can be expensive and difficult given the sheer number of compounds available. Filtering out the wrong compounds, sorting, and ranking the right compounds becomes more important than ever. Using Wisecube, enable a more focused approach on what molecules you spend your time evaluating and purchasing.
- Drug Repurposing. Using the best approaches for drug repurposing, Wisecube provides alternate opportunities for existing pharmaceutical lines. Given the high depreciation rates, high costs and slow approval processes of new drug discoveries, repurposing of previously approved drugs to treat diseases are becoming more attractive with the use of existing approved compounds, potentially lowering development costs and increasing revenue opportunities.
- Clinical Studies. Wisecube can assist in both designing, recruiting participants and running pre-clinical and clinical studies. By partnering with established CROs and leveraging the power of AI and the Wisecube platform we can optimize the outcomes of the clinical studies many fold.
